BDT 方案治疗多发性骨髓瘤的临床疗效.docx

文档word格式，可根据实际情况编辑修改BDT方案治疗多发性骨髓瘤的临床疗效BDT方案治疗多发性骨髓瘤的临床疗效林火真;代宏勋【期刊名称】现代肿瘤医学【年(卷),期】2016(024)016【摘要】Objective:TostudytheclinicalefficacyandsafetyofBDT(Bortezomib+Dexamethasone+Thalido-mide)regimeninthetreatmentofmultiplemyeloma(MM).Methods:Bortezomibinjectionwasused2timesperweek,m2,2consecutiveweeks(1,4,8,11days),Dexamethasone20mg,thefirst14din-travenousdrip,:Of31patientsMM,after3coursestreatment,completeremission(CR)in8cases,verygoodpartialremission(VGPR)in13cases,partialremission(PR)5cases,stabledisease(SD)in3ca-ses,%.Amongthem,theinitialtreatmentgroup21patients,%,relapsedorrefractorygroup10patients,%(P.Hemoglobin(HGB)wassignifi-cantlyincreased,theobservedindexesbeforeandaftertreatmentweresignificantlydifferent(P0.05).Conclusion:BDTcombinedwithchemotherapyregimeninthetreatmentofmultiplemyeloma(MM)completeremission(CR)ratewashigher,withlessadversereaction,relapsedorrefractoryMMpatientscanobtainsatisfactoryclinicaleffect.%目的：探讨应用BDT（硼替佐米地塞米松沙利度胺）方案2精选文档